Prognostic Values of Radiosensitivity Genes and CD19 Status in Gastric Cancer: A Retrospective Study Using TCGA Database

References

• G S, G V, V F, et al. Mast cells, angiogenesis and lymphangiogenesis in human gastric cancer. Int J Mol Sci. 2019;20(9).
   Web of Science ®Google Scholar
• Lott PC, Carvajal-Carmona LG. Resolving gastric cancer aetiology: an update in genetic predisposition. Lancet Gastroenterol Hepatol. 2018;3(12):874–883. doi:10.1016/S2468-1253(18)30237-130507471
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016;388(10060):2654–2664. doi:10.1016/S0140-6736(16)30354-327156933
   PubMed Web of Science ®Google Scholar
• Hartgrink H, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374(9688):477–490. doi:10.1016/S0140-6736(09)60617-619625077
   PubMed Web of Science ®Google Scholar
• Niccolai N, A A, Prisco D, A A. Gastric cancer and the epoch of immunotherapy approaches. World J Gastroenterol. 2015;21(19):5778–5793. doi:10.3748/wjg.v21.i19.577826019442
   PubMed Web of Science ®Google Scholar
• E N, D P, De MM, A A. What is recent in pancreatic cancer immunotherapy? Biomed Res Int. 2013;2013:492372.23509731
   PubMed Web of Science ®Google Scholar
• Yang L, Wang Y, Wang H. Use of immunotherapy in the treatment of gastric cancer. Oncol Lett. 2019;18(6):5681–5690. doi:10.3892/ol.2019.1093531788040
   PubMed Web of Science ®Google Scholar
• Katoh M, Katoh M. Precision medicine for human cancers with Notch signaling dysregulation (Review). Int J Mol Med. 2020;45(2):279–297. doi:10.3892/ijmm.2019.441831894255
   PubMed Web of Science ®Google Scholar
• Goebeler ME, Bargou R. Blinatumomab: a CD19/CD3 bispecific T cell engager (BiTE) with unique anti-tumor efficacy. Leuk Lymphoma. 2016;57(5):1021–1032. doi:10.3109/10428194.2016.116118527050240
   PubMed Web of Science ®Google Scholar
• A A, Bagos PG, Koutsandrea V, Georgakilas G. Molecular determinants of radiosensitivity in normal and tumor tissue: a bioinformatic approach. Cancer Lett. 2017;403:37–47. doi:10.1016/j.canlet.2017.05.02328619524
   PubMed Web of Science ®Google Scholar
• A A, Fortunato S. Consensus clustering in complex networks. Sci Rep. 2012;2:336. doi:10.1038/srep0033622468223
   PubMed Web of Science ®Google Scholar
• Jang B, Kim I. A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with glioblastoma multiforme in the cancer genome atlas dataset. Cancer Res Treatment. 2020;52(2):530–542. doi:10.4143/crt.2019.440
   Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv00725605792
   PubMed Web of Science ®Google Scholar
• Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284–287. doi:10.1089/omi.2011.011822455463
   PubMed Web of Science ®Google Scholar
• W W, Sánchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31(17):2912–2914. doi:10.1093/bioinformatics/btv30025964631
   PubMed Web of Science ®Google Scholar
• Liu J, Lichtenberg T, Hoadley K, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400–416.e411.29625055
   PubMed Web of Science ®Google Scholar
• Bs J, Ia K. A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with glioblastoma multiforme in the cancer genome atlas dataset. Cancer Res Treatment. 2019.
   Google Scholar
• Jang B-S, Kim IA. A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA. Radiotherapy Oncol. 2018;128(2):245–253. doi:10.1016/j.radonc.2018.05.003
   Web of Science ®Google Scholar
• Burnette B, Liang H, Lee Y, et al. The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity. Cancer Res. 2011;71(7):2488–2496. doi:10.1158/0008-5472.CAN-10-282021300764
   PubMed Web of Science ®Google Scholar
• Lee Y, Auh SL, Wang Y, et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood. 2009;114(3):589–595. doi:10.1182/blood-2009-02-20687019349616
   PubMed Web of Science ®Google Scholar
• Lugade AA, Moran JP, Gerber SA, Rose R, Frelinger JG, Lord EM. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. J Immunol. 2005;174(12):7516–7523. doi:10.4049/jimmunol.174.12.751615944250
   PubMed Web of Science ®Google Scholar
• Brudno JN, Kochenderfer JN. Recent advances in CAR T-cell toxicity: mechanisms, manifestations and management. Blood Rev. 2019;34:45–55. doi:10.1016/j.blre.2018.11.00230528964
   PubMed Web of Science ®Google Scholar
• Kruger S, M M, Kobold S, et al. Advances in cancer immunotherapy 2019 - latest trends. J Exp Clin Cancer Res. 2019;38(1):268. doi:10.1186/s13046-019-1266-031217020
   PubMed Web of Science ®Google Scholar
• Liu H, Tan H, Lin Y, Xu B, Zhao W, Xie Y. MicroRNA-1271-5p inhibits cell proliferation and enhances radiosensitivity by targeting CDK1 in hepatocellular carcinoma. J Biochem. 2020;167(5):513–524. doi:10.1093/jb/mvz11432275316
   PubMed Web of Science ®Google Scholar
• Wang J, Chang L, Lai X, et al. Tetrandrine enhances radiosensitivity through the CDC25C/CDK1/cyclin B1 pathway in nasopharyngeal carcinoma cells. Cell Cycle. 2018;17(6):671–680. doi:10.1080/15384101.2017.141567929285984
   PubMed Web of Science ®Google Scholar
• Fu S, Jin L, Gong T, et al. Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells. Oncol Rep. 2018;39(4):1601–1608. doi:10.3892/or.2018.622829393484
   PubMed Web of Science ®Google Scholar
• Prevo R, Pirovano G, Puliyadi R, et al. CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent manner. Cell Cycle. 2018;17(12):1513–1523. doi:10.1080/15384101.2018.149123630045664
   PubMed Web of Science ®Google Scholar
• Wei D, Parsels L, Karnak D, et al. Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C/CDK1 and homologous recombination repair. Clin Cancer Res. 2013;19(16):4422–4432. doi:10.1158/1078-0432.CCR-13-078823780887
   PubMed Web of Science ®Google Scholar
• Neganova I, Tilgner K, Buskin A, et al. CDK1 plays an important role in the maintenance of pluripotency and genomic stability in human pluripotent stem cells. Cell Death Dis. 2014;5:e1508. doi:10.1038/cddis.2014.46425375373
   PubMed Web of Science ®Google Scholar
• Orth M, Unger K, Schoetz U, Belka C, Lauber K. Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2. Oncogene. 2018;37(1):52–62. doi:10.1038/onc.2017.30428869599
   PubMed Web of Science ®Google Scholar
• Tchou J, Zhao Y, Levine L, et al. Safety and efficacy of intratumoral injections of chimeric antigen receptor (CAR) T cells in metastatic breast cancer. Cancer Immunol Res. 2017;5(12):1152–1161. doi:10.1158/2326-6066.CIR-17-018929109077
   PubMed Web of Science ®Google Scholar
• Zhao W, Jia L, Zhang M, et al. The killing effect of novel bi-specific Trop2/PD-L1 CAR-T cell targeted gastric cancer. Am J Cancer Res. 2019;9(8):1846–1856.31497363
   PubMed Web of Science ®Google Scholar